Market Overview:
The global N-Benzyl-N-Methylethanolamine (CAS 101-98-4) market is expected to register a CAGR of 5.5% during the forecast period 2018–2030. The market growth can be attributed to the increasing demand for N-Benzyl-N -Methylethanolamine in various applications such as antiasthmatic drug intermediate, antiallergy drug intermediate, herbicide intermediate, fungicide intermediate, preservative intermediary and others. Moreover, rising awareness about the benefits of using N -Benzyl -N Methylethanolamine is also propelling the growth of this market. However, volatility in prices of raw materials may hamper the growth of this market to some extent during the forecast period. Based on type, 99% purity type segment is projected to hold a dominant position in terms of revenue share throughout the forecast period 2018–2030 owing to its high purity and better performance as compared to other types available in the market.
Product Definition:
An amine that is used as a corrosion inhibitor and antifouling agent.
99% Purity Type:
99% purity type is a kind of chemicals that contains less than 0.1% impurities by weight. It's major applications include the synthesis of pharmaceuticals and agrochemicals, such as pesticides and herbicides, which are used in large quantities globally. 99% pure type also finds application in research laboratories for the study of chemical compounds due to its high quality standards compared to other commercial grades.
97% Purity Type:
97% purity type is a kind of pharmaceutical grade material which has been tested and found to be free from all types of impurities. It means that the sample meets all the requirements set by FDA, EU, etc. 97% pure type can also be called as high purity or top quality material.
It is used in manufacturing N-Benzyl-N-Methylethanolamine (CAS 101-98-4).
Application Insights:
The global market is segmented by application into an asthma drug intermediate, anti-allergy drug intermediate, herbicide intermediate, fungicide intermediate and other applications. The asthma drug Intermediate segment dominated the overall market in terms of revenue share in 2017. This high share is attributable to the rising prevalence of asthma across the globe coupled with increasing R&D investments for developing new drugs for treatment of this disease.
The anti-allergy drug Intermediate segment is expected to grow at a lucrative rate over the forecast period owing to growing demand for such products from patients suffering from allergic rhinitis and eczema as well as skin rashes caused due to poison oak or ivy contact allergy.
Regional Analysis:
Asia Pacific is expected to be the fastest-growing regional market with a CAGR of XX% from 2018 to 2030 owing to increasing product demand in pharmaceutical, agrochemical, and other industries. The region is anticipated to witness significant growth due to rising population coupled with rapid urbanization and industrialization in countries such as China, India, Indonesia, Malaysia Philippines Singapore Thailand Vietnam etc.
The presence of various chemical manufacturers coupled will low manufacturing cost has attracted major global players such as INEOS Chemical Company Limited; Sinopec Shanghai Petrochemicals Corporation; Chevron Phillips Chemical Co.; OxyChem Corp.; BASF SE; Shell Chemicals Netherlands BV; etc., for setting up their production facilities in the Asia Pacific region which further drives product demand over the forecast period.
Growth Factors:
- Increasing demand from end-use industries such as pharmaceuticals, agrochemicals, and flavors and fragrances is expected to drive the growth of the N-Benzyl-N-Methylethanolamine (CAS 101-98-4) market over the forecast period.
- Growing awareness about the benefits of using N-Benzyl-N -Methylethanolamine (CAS 101 -98 -4) in various end user applications is projected to fuel market growth.
- The increasing use of N -Benzyl -N Methylethanolamine ( CAS 101 – 98 – 4 ) in personal care products is anticipated to propel market demand over the forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Research Report
By Type
99% Purity Type, 97% Purity Type, 95% Purity Type, 90% Purity Type, Others
By Application
Antiasthmatic Drug Intermediate, Anti-Allergy Drug Intermediate, Herbicide Intermediate, Fungicide Intermediate, Preservative Intermediate, Others
By Companies
Rui Ming Pharmaceutical, Goss Pharm., Lullaby Pharm., Biosynth, Clearsynth, A Chemtek, Vlada Chem, Key Organics, Meryer, Energy Chemical, Oakwood Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Report Segments:
The global N-Benzyl-N-Methylethanolamine (CAS 101-98-4) market is segmented on the basis of:
Types
99% Purity Type, 97% Purity Type, 95% Purity Type, 90% Purity Type, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Antiasthmatic Drug Intermediate, Anti-Allergy Drug Intermediate, Herbicide Intermediate, Fungicide Intermediate, Preservative Intermediate, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Rui Ming Pharmaceutical
- Goss Pharm.
- Lullaby Pharm.
- Biosynth
- Clearsynth
- A Chemtek
- Vlada Chem
- Key Organics
- Meryer
- Energy Chemical
- Oakwood Chemical
Highlights of The N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 99% Purity Type
- 97% Purity Type
- 95% Purity Type
- 90% Purity Type
- Others
- By Application:
- Antiasthmatic Drug Intermediate
- Anti-Allergy Drug Intermediate
- Herbicide Intermediate
- Fungicide Intermediate
- Preservative Intermediate
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
N-Benzyl-N-methylethanolamine is a chemical compound with the molecular formula C10H16N2O. It is a white solid that is soluble in water and most organic solvents. N-Benzyl-N-methylethanolamine has been used as an intermediate in the production of other chemicals, including pesticides and plastics.
Some of the key players operating in the n-benzyl-n-methylethanolamine (cas 101-98-4) market are Rui Ming Pharmaceutical, Goss Pharm., Lullaby Pharm., Biosynth, Clearsynth, A Chemtek, Vlada Chem, Key Organics, Meryer, Energy Chemical, Oakwood Chemical.
The n-benzyl-n-methylethanolamine (cas 101-98-4) market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market - Supply Chain
4.5. Global N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Forecast
4.5.1. N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size (000 Units) and Y-o-Y Growth
4.5.3. N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Absolute $ Opportunity
5. Global N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size and Volume Forecast by Type
5.3.1. 99% Purity Type
5.3.2. 97% Purity Type
5.3.3. 95% Purity Type
5.3.4. 90% Purity Type
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size and Volume Forecast by Application
6.3.1. Antiasthmatic Drug Intermediate
6.3.2. Anti-Allergy Drug Intermediate
6.3.3. Herbicide Intermediate
6.3.4. Fungicide Intermediate
6.3.5. Preservative Intermediate
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Demand Share Forecast, 2019-2026
9. North America N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size and Volume Forecast by Application
9.4.1. Antiasthmatic Drug Intermediate
9.4.2. Anti-Allergy Drug Intermediate
9.4.3. Herbicide Intermediate
9.4.4. Fungicide Intermediate
9.4.5. Preservative Intermediate
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size and Volume Forecast by Type
9.7.1. 99% Purity Type
9.7.2. 97% Purity Type
9.7.3. 95% Purity Type
9.7.4. 90% Purity Type
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Demand Share Forecast, 2019-2026
10. Latin America N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size and Volume Forecast by Application
10.4.1. Antiasthmatic Drug Intermediate
10.4.2. Anti-Allergy Drug Intermediate
10.4.3. Herbicide Intermediate
10.4.4. Fungicide Intermediate
10.4.5. Preservative Intermediate
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size and Volume Forecast by Type
10.7.1. 99% Purity Type
10.7.2. 97% Purity Type
10.7.3. 95% Purity Type
10.7.4. 90% Purity Type
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Demand Share Forecast, 2019-2026
11. Europe N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size and Volume Forecast by Application
11.4.1. Antiasthmatic Drug Intermediate
11.4.2. Anti-Allergy Drug Intermediate
11.4.3. Herbicide Intermediate
11.4.4. Fungicide Intermediate
11.4.5. Preservative Intermediate
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size and Volume Forecast by Type
11.7.1. 99% Purity Type
11.7.2. 97% Purity Type
11.7.3. 95% Purity Type
11.7.4. 90% Purity Type
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Demand Share, 2019-2026
12. Asia Pacific N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size and Volume Forecast by Application
12.4.1. Antiasthmatic Drug Intermediate
12.4.2. Anti-Allergy Drug Intermediate
12.4.3. Herbicide Intermediate
12.4.4. Fungicide Intermediate
12.4.5. Preservative Intermediate
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size and Volume Forecast by Type
12.7.1. 99% Purity Type
12.7.2. 97% Purity Type
12.7.3. 95% Purity Type
12.7.4. 90% Purity Type
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Demand Share, 2019-2026
13. Middle East & Africa N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size and Volume Forecast by Application
13.4.1. Antiasthmatic Drug Intermediate
13.4.2. Anti-Allergy Drug Intermediate
13.4.3. Herbicide Intermediate
13.4.4. Fungicide Intermediate
13.4.5. Preservative Intermediate
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market Size and Volume Forecast by Type
13.7.1. 99% Purity Type
13.7.2. 97% Purity Type
13.7.3. 95% Purity Type
13.7.4. 90% Purity Type
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market: Market Share Analysis
14.2. N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Distributors and Customers
14.3. N-Benzyl-N-Methylethanolamine (CAS 101-98-4) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Rui Ming Pharmaceutical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Goss Pharm.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Lullaby Pharm.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Biosynth
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Clearsynth
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. A Chemtek
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Vlada Chem
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Key Organics
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Meryer
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Energy Chemical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Oakwood Chemical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
&